Baidu
map

AlphaGo进军医疗保健领域

2016-03-18 大数据文摘 大数据文摘

谷歌旗下的DeepMind以开发尖端的自主学习软件而出名,这几天该公司开发的人工智能机器人AlphaGo正在挑战排名世界第一的韩国围棋选手李世石,整个互联网也因此搅的天翻地覆。硝烟未尽,肩负谷歌母公司Alphabet进军生命科学的神圣使命,DeepMind将携其强大的机器学习算法,在医疗保健领域开辟新战场。DeepMind健康部与医生共同打造医疗软件作为一家被网络搜索服务提供商所拥有的人工智能公司

谷歌旗下的DeepMind以开发尖端的自主学习软件而出名,这几天该公司开发的人工智能机器人AlphaGo正在挑战排名世界第一的韩国围棋选手李世石,整个互联网也因此搅的天翻地覆。

硝烟未尽,肩负谷歌母公司Alphabet进军生命科学的神圣使命,DeepMind将携其强大的机器学习算法,在医疗保健领域开辟新战场。

DeepMind健康部与医生共同打造医疗软件

作为一家被网络搜索服务提供商所拥有的人工智能公司,DeepMind正通过将它的专长运用到医疗保健领域向医疗技术产业进军。

DeepMind周三表示,它的伦敦子公司已与伦敦帝国理工学院和伦敦皇家自由NHS信托基金会强强联手,成立DeepMind Health。DeepMind的联合创始人穆斯塔法·苏莱曼(MustafaSuleyman)表示,这一目前只有15人的新部门在未来将会迅速发展。公司还聘请了两名医生一起工作,来指导研发工作。

其中一名医生是多米尼克·金(Dominic King),他是一家英国医疗创业公司Hark的技术开发者之一,这家公司现已被DeepMind收购,作为进军医疗技术领域业务的一部分。Hark曾经为临床医生开发了一款任务管理的智能手机应用程序。

苏莱曼表示:“目前,我们主要致力于建立与临床医生之间的信任,并与医生和护士一起打造新产品。”最终,DeepMind希望能将它的机器学习技术应用到医疗保健领域。

DeepMindHealth设计了一个叫作Streams的软件。在皇家自由医院的试点项目中,它可以让医生快速查看体检结果。该院的病人安全医疗副主任克里斯·莱恩(Chris Laing)说,Streams 让他在几秒钟内查看病人的血液测试结果,判断急性肾损伤的风险,并改善病人护理。 “该系统能直接警报,而且有优先考虑病人的能力,这在之前是不可能的。”莱恩说。

此次合作很大部分由谷歌母公司Alphabet促成,是该公司向康技术研究领域的拓展。这家总部位于加州的山景城的公司还经营一个生命科学的研究小组 Verily,以及一家抗衰老公司Calico,而谷歌本身也在进行一些基础科学研究。此公司还搭建了精巧的云计算系统用于英国的医疗机构,这些机构分离于谷歌的主要基础设施。

“DeepMind的长期目标是提供临床医生一些工具,来使用和分析不堪重负的大量信息流。”苏莱曼说。

人工智能助力医疗大数据挖掘

海量的医疗数据处理,需要更强的算法。近年来,除了传统的统计分析算法,深度学习(DeepLearning)和人工智能成了从海量数据中获取知识的有力武器,在基于大数据的医疗研究应用中也逐渐显示出优势。举几个例子:

- IBM在2015年宣布,其超级计算机Watson开始提供基因组数据分析,帮助医生为癌症及其他疾病的治疗提供依据。

-加拿大的一家公司Deep Genomics利用深度学习技术从基因组的非编码区段找到了和癌症密切相关的变异位点。

-位于旧金山的美国公司Enlitic(enlitic.com)则致力于用大数据和深度学习作出更加精确的临床诊断。

随着计算机技术的继续发展,随着云计算、移动互联网及物联网的到来,机器学习及人工智能将会如火如荼,助力医疗研究,将医疗带入一个崭新的未来。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-08-23 jiekemin
  2. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-04-26 yhy100200
  3. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-21 医者仁心5538

    好!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-20 壹生

    AlphaGo为谷歌赚足了眼球

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-20 lovetcm

    要做人工智能,我们国内百度做外卖,差距大呀

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-19 wei834766788

    不错的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2035984, encodeId=afde2035984bf, content=<a href='/topic/show?id=01482345fc' target=_blank style='color:#2F92EE;'>#ALP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2345, encryptionId=01482345fc, topicName=ALP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82369, createdName=jiekemin, createdTime=Tue Aug 23 05:09:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2347, encryptionId=20dc234e94, topicName=Alpha)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Apr 26 14:09:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079687, encodeId=3d6920e96874a, content=<a href='/topic/show?id=5b0423540c' target=_blank style='color:#2F92EE;'>#AlphaGo#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2354, encryptionId=5b0423540c, topicName=AlphaGo)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Tue Feb 07 15:09:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706761, encodeId=ff961e067619a, content=<a href='/topic/show?id=628a30e3012' target=_blank style='color:#2F92EE;'>#军医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30730, encryptionId=628a30e3012, topicName=军医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af031318295, createdName=ms691033630344116, createdTime=Wed Oct 05 20:09:00 CST 2016, time=2016-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72080, encodeId=e738e2080b4, content=好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Mar 21 06:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71991, encodeId=5ab6e1991f6, content=AlphaGo为谷歌赚足了眼球, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160227/IMG56D1078DD4F344111.jpg, createdBy=80b71692457, createdName=壹生, createdTime=Sun Mar 20 12:53:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71982, encodeId=e947e198270, content=要做人工智能,我们国内百度做外卖,差距大呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Mar 20 10:36:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525856, encodeId=c85e1525856f6, content=<a href='/topic/show?id=22a03480efa' target=_blank style='color:#2F92EE;'>#医疗保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34807, encryptionId=22a03480efa, topicName=医疗保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eb511671747, createdName=drj2007, createdTime=Sun Mar 20 04:09:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71637, encodeId=c827e163784, content=不错的, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=71638, encodeId=f74ae163881, content=但愿越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 19 11:13:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]
    2016-03-19 wei834766788

    但愿越来越好

    0

相关资讯

AlphaGo是什么鬼?告诉你20世纪的十大算法

本世纪初,美国物理学会(American Institute of Physics)和IEEE计算机社团 (IEEE Computer Society)的一本联合刊物《科学与工程中的计算》发表了由田纳西大学的Jack Dongarra和橡树岭国家实验室的Francis Sullivan 联名撰写的“世纪十大算法”一文,该 文“试图整理出在20世纪对科学和工程领域的发展产生最

Baidu
map
Baidu
map
Baidu
map